Biomotion Sciences Ordinary Shares (SLXN) — Capital Reinvestment Ratio

Latest as of December 2022: 0.00x

Biomotion Sciences Ordinary Shares (SLXN) has a Capital Reinvestment Ratio of 0.00x as of December 2022, meaning it reinvests 0% of its operating cash flow ($660.30K) in capital expenditures ($3.00). See Biomotion Sciences Ordinary Shares balance sheet quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$660.30K

USD

Capital Expenditures

$3.00

USD

Data as of

Dec 2022

Most recent filing

Annual Capital Reinvestment Ratio for Biomotion Sciences Ordinary Shares (None–None)

Year-by-year Capital Reinvestment Ratio for Biomotion Sciences Ordinary Shares from None to None. For live market cap and broader valuation context, see Biomotion Sciences Ordinary Shares stock valuation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow